This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Organon & Co.’s 8K filing here.
About Organon & Co.
Organon & Co is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.
Featured Stories
- Five stocks we like better than Organon & Co.
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Bloom Energy: Powering the Future With Decentralized Energy
- Using the MarketBeat Stock Split Calculator
- Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul
- How to Invest in Biotech Stocks
- Why Traders Are Buying the Dip on Johnson & Johnson Stock
